[(1-isopropyl-1,2,3,4-tetrahydro-6-quinolinyl)methyl]methylamine oxalate, 95.0%, 1g

2-(7-Methoxynaphthalen-1-yl)acetamide, 95.0%, 500mg

2-Chloro-5-methylpyridine, 97.0%, 500g

2-Amino-5-ethynylpyrimidine, 95.0%, 5g

2-Chloro-5-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95+%, 5g

6-Fluoro-5-iodopyridin-2-ol, 95.0%, 1g

2-Bromo-9-N-octyl-9H-carbazole, 98%, 1g

2-BROMO-4-HYDROXYNICOTINONITRILE, 95.0%, 250mg

5,10,15,20-Tetrakis(3,5-dihydroxyphenyl)porphyrin>90.0%(HPLC)100mg

1-ethyl-6-(3-methoxyphenyl)-3-methyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid, 95.0%, 5g

Methyl 4-cyanofuran-2-carboxylate, 95.0%, 1g

1-Amino-3-phenylpropan-2-one hydrochloride, 98%, 250mg

Periodate de sodium, min 99,8 %, pa, ACS, 250 g, emballage plastique.